CD38 in Adenosinergic Pathways and Metabolic Re-programming in Human Multiple Myeloma Cells: In-tandem Insights From Basic Science to TherapyAlberto L. Horenstein(University of Turin), Fabio Malavasi(University of Turin)Frontiers in ImmunologyApril 24, 201910.3389/fimmu.2019.00760Cited by 68SaveCiteExport RISWatch citationsRelated PapersCD38 antibodies in multiple myeloma: back to the future|Blood|2017|482CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential|Blood|2007|160A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation|Oncotarget|2015|95